|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00241 ALI HEALTH
Nominal 
3.510 +0.050 (+1.445%) | 2024/03 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/03 RMB(K¥) | 2022/03 RMB(K¥) | 2021/03 RMB(K¥) | 2020/03 RMB(K¥) | |
| Turnover | 27,026,555 | 0.985% | 26,763,016 | 20,577,616 | 15,518,468 | 9,596,476 |
| Cost of Sales | (21,131,234) | 0.330% | (21,061,682) | (16,469,623) | (11,901,219) | (7,365,096) |
| Gross Profit | 5,895,321 | 3.402% | 5,701,334 | 4,107,993 | 3,617,249 | 2,231,380 |
| 2024/03 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/03 RMB(K¥) | 2022/03 RMB(K¥) | 2021/03 RMB(K¥) | 2020/03 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (5,926) | -- | 11,381 | (45,620) | (38,413) | (34,032) | |
| Profit / (Loss) before Taxation | 939,399 | 70.492% | 550,994 | (252,514) | 401,219 | 9,094 | |
| Taxation | (56,263) | 288.423% | (14,485) | (13,427) | (58,539) | (24,790) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 341 | -- | (856) | 386 | 5,908 | 9,110 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 883,477 | 64.935% | 535,653 | (265,555) | 348,588 | (6,586) | |
| 2024/03 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/03 RMB(K¥) | 2022/03 RMB(K¥) | 2021/03 RMB(K¥) | 2020/03 RMB(K¥) | |
| Net Finance Costs / (Income) | (472,061) | 44.913% | (325,755) | (206,023) | (162,966) | (34,246) |
| Depreciation & Amortisation | 53,682 | -15.752% | 63,719 | 60,576 | 39,626 | 41,689 |
| Directors' Emoluments | 32,547 | 46.325% | 22,243 | 27,436 | 26,601 | 28,427 |
| 2024/03 - Final | %Chg (Compare to Final) | 2023/03 | 2022/03 | 2021/03 | 2020/03 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/03 - Final | %Chg (Compare to Final) | 2023/03 | 2022/03 | 2021/03 | 2020/03 | |
| EPS (cts) | 6.290 | 58.438% | 3.970 | -1.970 | 2.630 | -0.060 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 0.077 | -- | 0.019 | 0.031 | 0.076 | 0.049 |
| NBV per share ($) | 0.904 | -- | 1.122 | 1.043 | 1.060 | 0.436 |
| Remarks: | Real time quote last updated: 24/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 768,953 |
| %Change | 72.453% |
| EPS / (LPS) | RMB 0.048 |
| NBV Per Share (¥) | RMB 0.949 |